Filana Therapeutics, Inc. (FLNA)
Nasdaq: FLNA · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2000
Filings
301 filings since 2017 beside 150 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
4348343853685122
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 14 times in the last 36 months, the newest Nov 12, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Sep 18, 2026.SEC letters: 1 in the last 36 months, the newest Dec 3, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Nov 8, 2026
Sep 22, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jun 15, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 11, 2026
Mar 10, 2026
8-K items 5.03, 7.01, 9.01
Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Feb 19, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Dec 22, 2025
8-K/A items 5.02, 9.01
Officer or director change · Current report, amended
Oct 21, 2025
Oct 22, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Oct 21, 2025
Aug 4, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
May 27, 2025
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 23, 2025
40 of 301 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.